Physician profile
Mark A Kuzich
NPI 1033347265
$6,938.36
in general payments reported to CMS, 2019-2025
5 companies · $90.83 in 2025
The $90.83 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $6,798 · 2024: $49.04 · 2025: $90.83.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $5,512 · Travel and Lodging: $919 · Food and Beverage: $496 · Gift: $11.26.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $5,512.45 |
| Travel and Lodging | $918.89 |
| Food and Beverage | $495.76 |
| Gift | $11.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,715.53 | 2023-2024 | Davinci Xi, Da Vinci Surgical System, Da Vinci Sp |
| Smith+Nephew, INC. | $118.86 | 2024-2025 | Renasys Touch, Stravix Pl, Pico |
| Edwards Lifesciences Corporation | $47.50 | 2023 | Hemosphere |
| Tela Bio, INC. | $41.26 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Abbvie INC. | $15.21 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Kuzich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.